Polymorphisms in hOGG1 and XRCC1 and Risk of Prostate Cancer: Effects Modified by Plasma Antioxidants
To access this article, please choose from the options below
This study is supported by grants from the Centers for Disease Control and Prevention through the Arkansas Comprehensive Cancer Control Program (116-1005406, Dr. Zhang, PI) and from the National Institute on Aging, NIH (1R01AG15722, Dr. Lang, PI).
PII: S0090-4295(09)02505-9
doi:10.1016/j.urology.2009.08.063
© 2010 Elsevier Inc. All rights reserved.
